The Mystery TT Virus--What Is It?

For this article, Leslie Pray interviewed Isa Mushahwar, consultant and retired distinguished research fellow and director of the Virus Discovery Group, Abbott Laboratories, North Chicago, Ill. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. I.K. Mushahwar et al. J.C. Erker, A.S. Muerhoff, T.P Leary, J.N. Simons, L.G. Birkenmeyer, M.L. Chalmers, T.J. Pilot-Matias, S.M. Dexai, "Molecular

Written byLeslie Pray
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Most hepatitis cases are caused by one of the five main hepatitis viruses, A-E, "but in the U.S. alone, it is estimated that there are 68,000 cases of post-transfusion hepatitis of unknown etiology still taking place among blood recipients," says Isa Mushahwar, who served as distinguished research fellow and director of the Virus Discovery Group, Abbott Laboratories, North Chicago, Ill., until his retirement in April. Mushahwar is now a consultant for the group, which was established in 1993 to look for a new hepatitis virus to account for all the unexplained cases of hepatitis.

Because of its speculated causal link to hepatitis, TTV quickly became the object of intense scrutiny for Mushahwar and his colleagues. They were the first research team to reveal the virus' complete nucleotide sequence, circular nature, and certain biochemical and biophysical characteristics. They found that even though the new virus shares some structural similarities with viruses ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies